PAPER Samadi H, Sultzer D
SEARCH RESULTS
329930 RESULTS
PAPER Piette F, Belmin J, Vincent H, Schmidt N, Pariel S, Verny M, Marquis C, Mely J, Hugonot-Diener L, Kinet JP, Dubreuil P, Moussy A, Hermine O
Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial.
Alzheimers Res Ther. 2011 Apr 19;3(2):16. PubMed: 21504563PAPER Kim S, Chang WE, Kumar R, Klimov DK
Naproxen interferes with the assembly of Aβ oligomers implicated in Alzheimer's disease.
Biophys J. 2011 Apr 20;100(8):2024-32. PubMed: 21504739PAPER Lamar M, Foy CM, Beacher F, Daly E, Poppe M, Archer N, Prasher V, Murphy KC, Morris RG, Simmons A, Lovestone S, Murphy DG
Down syndrome with and without dementia: an in vivo proton Magnetic Resonance Spectroscopy study with implications for Alzheimer's disease.
Neuroimage. 2011 Jul 1;57(1):63-8. PubMed: 21504795PAPER Yoo YJ, Nam DH, Jung SY, Jang JW, Kim HJ, Jin C, Pae AN, Lee YS
Synthesis of cinnamoyl ketoamides as hybrid structures of antioxidants and calpain inhibitors.
Bioorg Med Chem Lett. 2011 May 15;21(10):2850-4. PubMed: 21504847PAPER Gavrilova SI, Kolykhalov IV, Fedorova YB, Selezneva ND, Kalyn YB, Roshchina IF, Odinak MM, Emelin AY, Kashin AV, Gustov AV, Antipenko EA, Korshunova YA, Davydova TA, Messler G
Potential of preventive treatment of Alzheimer's disease: results of a three-year prospective open comparative trial of the efficacy and safety of courses of treatment with cerebrolysin and cavinton in elderly patients with mild cognitive impairment syndr
Neurosci Behav Physiol. 2011 May;41(4):391-8. PubMed: 21505745PAPER Potteaux S, Gautier EL, Hutchison SB, van Rooijen N, Rader DJ, Thomas MJ, Sorci-Thomas MG, Randolph GJ